1. ScholarBank@NUS

H. Phillip Koeffler

rp05987

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
H. Phillip Koeffler
Variants
Phillip Koeffler, H.
Koeffler Philip H.
Koeffler H.P.
Koeffler, H.P.
 
Main Affiliation
 
Faculty
 
Email
mdchpk@nus.edu.sg
 
Other emails
 

Publications

Results 61-80 of 94 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
612017Mutational profiling of acute lymphoblastic leukemia with testicular relapseDing, L.-W ; Sun, Q.-Y ; Mayakonda, A ; Tan, K.-T ; Chien, W ; Lin, D.-C ; Jiang, Y.-Y ; Xu, L ; Garg, M ; Lao, Z.-T ; Lill, M.; Yang, H ; Yeoh, A.E.J ; Koeffler, H.P 
226-Aug-2020Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomasJeitany, Maya ; Prabhu, Aishvaryaa; Dakle, Pushkar ; Pathak, Elina; Madan, Vikas ; Kanojia, Deepika ; Mukundan, Vineeth ; Jiang, Yan Yi ; Landesman, Yosef; Tam, Wai Leong ; Kappei, Dennis ; Koeffler, H. Phillip 
3Aug-2011Novel CUX1 missense mutation in association with 7q- at leukemic transformation of MPNThoennissen, N.H.; Lasho, T.; Thoennissen, G.B.; Ogawa, S.; Tefferi, A.; Koeffler, H.P. 
41-Jan-2014Novel Gemini vitamin D3 analogs: Large structure/function analysis and ability to induce antimicrobial peptideOkamoto, R.; Gery, S.; Kuwayama, Y.; Borregaard, N.; Ho, Q.; Alvarez, R.; Akagi, T.; Liu, G.Y.; Uskokovic, M.R.; Koeffler, H.P. 
5Jan-2013Off-target effects of c-MET inhibitors on thyroid cancer cellsZhou, Y.; Zhao, C.; Gery, S.; Braunstein, G.D.; Okamoto, R.; Alvarez, R.; Miles, S.A.; Doan, N.B.; Said, J.W.; Gu, J.; Phillip Koeffler, H. 
6Apr-2012Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysisKoren-Michowitz, M.; Sato-Otsubo, A.; Nagler, A.; Haferlach, T.; Ogawa, S.; Koeffler, H.P. 
72014Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinomaJin, S; Wang, K; Xu, K; Xu, J; Sun, J; Chu, Z; Lin, D ; Koeffler, P.H ; Wang, J; Yin, D
82013Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survivalLee, D.H.; Amanat, S.; Goff, C.; Weiss, L.M.; Said, J.W.; Doan, N.B.; Sato-Otsubo, A.; Ogawa, S.; Forscher, C.; Koeffler, H.P. 
91988P53 in chronic myelogenous leukemia: Study of mechanisms of differential expressionLübbert, M; Miller, C.W; Crawford, L; Koeffler, H.P 
102020PARK2 promotes mitochondrial pathway of apoptosis and antimicrotubule drugs chemosensitivity via degradation of phospho-BCL-2Chen, H.; Li, Y.; Li, Y.; Chen, Z.; Xie, L.; Li, W.; Zhu, Y.; Xue, H.; Phillip Koeffler, H. ; Wu, W.; Hu, K.; Yin, D.
118-Apr-2010Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasmsThoennissen, N.H.; Krug, U.O.; Lee, D.H.T.; Kawamata, N.; Iwanski, G.B.; Lasho, T.; Weiss, T.; Nowak, D.; Koren-Michowitz, M.; Kato, M.; Sanada, M.; Shih, L.-Y.; Nagler, A.; Raynaud, S.D.; Müller-Tidow, C.; Mesa, R.; Haferlach, T.; Gilliland, D.G.; Tefferi, A.; Ogawa, S.; Phillip Koeffler, H. 
122018Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines 11 Medical and Health Sciences 1107 ImmunologyTan, K.-T ; Ding, L.-W ; Sun, Q.-Y ; Lao, Z.-T ; Chien, W ; Ren, X; Xiao, J.-F ; Loh, X.Y ; Xu, L ; Lill, M; Mayakonda, A ; Lin, D.-C; Yang, H ; Koeffler, H.P 
132019Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinationsLim, S.L.; Damnernsawad, A.; Shyamsunder, P. ; Chng, W.J. ; Han, B.C.; Xu, L. ; Pan, J.; Pravin, D.P. ; Alkan, S.; Tyner, J.W.; Koeffler, H.P. 
149-Mar-2012RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathwayShi, S.; Deng, Y.-Z.; Zhao, J.-S.; Ji, X.-D.; Shi, J.; Feng, Y.-X.; Li, G.; Li, J.-J.; Zhu, D.; Koeffler, H.P. ; Zhao, Y.; Xie, D.
15Oct-2013Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasmsKon, A.; Shih, L.-Y.; Minamino, M.; Sanada, M.; Shiraishi, Y.; Nagata, Y.; Yoshida, K.; Okuno, Y.; Bando, M.; Nakato, R.; Ishikawa, S.; Sato-Otsubo, A.; Nagae, G.; Nishimoto, A.; Haferlach, C.; Nowak, D.; Sato, Y.; Alpermann, T.; Nagasaki, M.; Shimamura, T.; Tanaka, H.; Chiba, K.; Yamamoto, R.; Yamaguchi, T.; Otsu, M.; Obara, N.; Sakata-Yanagimoto, M.; Nakamaki, T.; Ishiyama, K.; Nolte, F.; Hofmann, W.-K.; Miyawaki, S.; Chiba, S.; Mori, H.; Nakauchi, H.; Koeffler, H.P. ; Aburatani, H.; Haferlach, T.; Shirahige, K.; Miyano, S.; Ogawa, S.
1627-Jun-2013Role of the adaptor protein LNK in normal and malignant hematopoiesisGery, S.; Koeffler, H.P. 
172014Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cellsChien W. ; Ding L.-W. ; Sun Q.-Y. ; Torres-Fernandez L.A.; Tan S.Z.; Xiao J. ; Lim S.L. ; Garg M. ; Lee K.L. ; Kitajima S. ; Takao S. ; Leong W.Z. ; Sun H.; Tokatly I.; Poellinger L. ; Gery S.; Koeffler P.H. 
182017Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinGarg, M ; Kanojia, D ; Mayakonda, A ; Ganesan, T.S; Sadhanandhan, B; Suresh, S; Sneha, S; Nagare, R.P; Said, J.W; Doan, N.B; Ding, L.-W ; Baloglu, E; Shacham, S; Kauffman, M; Koeffler, H.P 
1931-Aug-2021Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation statusMarijon, Hélène; Gery, Sigal; Chang, Hua; Landesman, Yosef; Shacham, Sharon; Lee, Dhong Hyun; de Gramont, Aimery; Koeffler, Harold Phillip 
202015SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathwaySun Qiao Yang ; Ding Ling Wen ; Xiao Jin Fen; Chien Wen Wen ; Lim Su Lin ; Hattori Norimichi; Goodglick Lee; Chia David; Mah Vei; Alavi Mohammad; Kim S.R.,; Doan N.B.; Said J.W; Loh Xin Yi ; Xu Liang ; Liu Li Zhen ; Yang Henry ; Takahide Hayano ; Shi Shuo; Xie Dong; Lin De Chen ; Koeffler Philip H.